Keybanc Initiates Coverage On Guardian Pharmacy Service with Overweight Rating, Announces Price Target of $52
9/23/2026
Impact: 70
Healthcare
Keybanc analyst Zach Haggerty has initiated coverage on Guardian Pharmacy Service (NYSE: GRDN) with an Overweight rating. The firm has set a price target of $52 for the stock.
AI summary, not financial advice
Share: